Ganglioside inhibition of CD8+ T cell cytotoxicity: Interference with lytic granule trafficking and exocytosis

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3521-3527

  Lee, Hee Chul ^a,b   Wondimu, Assefa ^a   Liu, Yihui ^a   Ma, Jennifer S Y ^a,b   Radoja, Saša ^a,b   Ladisch, Stephan ^a  

^a CHILDREN S RESEARCH INSTITUTE   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL GRANULE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXOCYTOSIS; IMMUNOLOGICAL SYNAPSE; IN VITRO STUDY; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DEGRANULATION; CELL LINE, TUMOR; CYTOPLASMIC GRANULES; CYTOTOXICITY TESTS, IMMUNOLOGIC; EXOCYTOSIS; GANGLIOSIDES; IMMUNOLOGICAL SYNAPSES; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA L1210; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL;

EID: 84866536027     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201256     Document Type: Article

References (46)

1. Russell, J. H., and T. J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 20: 323-370. (Pubitemid 34293428)
2. Stinchcombe, J. C., and G. M. Griffiths. 2007. Secretory mechanisms in cellmediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 23: 495-517.
3. Frey, A. B., and N. Monu. 2008. Signaling defects in anti-tumor T cells. Immunol. Rev. 222: 192-205. (Pubitemid 351430368)
4. Rabinovich, G. A., D. Gabrilovich, and E. M. Sotomayor. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25: 267-296. (Pubitemid 46697910)
5. Ladisch, S., B. Gillard, C. Wong, and L. Ulsh. 1983. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res. 43: 3808-3813. (Pubitemid 13077709)
6. Ladisch, S., and Z. L. Wu. 1985. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet 325: 136-138. (Pubitemid 15152470)
7. Bernhard, H., K. H. Meyer zum Büschenfelde, and W. G. Dippold. 1989. Ganglioside GD3 shedding by human malignant melanoma cells. Int J. Cancer 44: 155-160.
8. Merritt, W. D., V. Der-Minassian, and G. H. Reaman. 1994. Increased GD3 ganglioside in plasma of children with T-cell acute lymphoblastic leukemia. Leukemia 8: 816-822.
9. Uzzo, R. G., P. Rayman, V. Kolenko, P. E. Clark, M. K. Cathcart, T. Bloom, A. C. Novick, R. M. Bukowski, T. Hamilton, and J. H. Finke. 1999. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kB activation in T cells. J. Clin. Invest. 104: 769-776. (Pubitemid 29536362)
10. Caldwell, S., A. Heitger, W. Shen, Y. Liu, B. Taylor, and S. Ladisch. 2003. Mechanisms of ganglioside inhibition of APC function. J. Immunol. 171: 1676-1683. (Pubitemid 36966449)
11. Rayman, P., A. K. Wesa, A. L. Richmond, T. Das, K. Biswas, G. Raval, W. J. Storkus, C. Tannenbaum, A. Novick, R. Bukowski, and J. Finke. 2004. Effect of renal cell carcinomas on the development of type 1 T-cell responses. Clin. Cancer Res. 10: 6360S-6366S. (Pubitemid 39287492)
12. Bergelson, L. D., E. V. Dyatlovitskaya, T. E. Klyuchareva, E. V. Kryukova, A. F. Lemenovskaya, V. A. Matveeva, and E. V. Sinitsyna. 1989. The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Eur. J. Immunol. 19: 1979-1983. (Pubitemid 20017700)
13. Kimata, H., and A. Yoshida. 1994. Differential effects of gangliosides on Ig production and proliferation by human B cells. Blood 84: 1193-1200. (Pubitemid 24245884)
14. Thornton, M. V., D. Kudo, P. Rayman, C. Horton, L. Molto, M. K. Cathcart, C. Ng, E. Paszkiewicz-Kozik, R. Bukowski, I. Derweesh, et al. 2004. Degradation of NF-κB in T cells by gangliosides expressed on renal cell carcinomas. J. Immunol. 172: 3480-3490. (Pubitemid 38337928)
15. Crespo, F. A., X. Sun, J. G. Cripps, and R. Fernandez-Botran. 2006. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses. J. Leukoc. Biol. 79: 586-595. (Pubitemid 44831235)
16. Shen, W., R. Falahati, R. Stark, D. Leitenberg, and S. Ladisch. 2005. Modulation of CD4 Th cell differentiation by ganglioside GD1a in vitro. J. Immunol. 175: 4927-4934. (Pubitemid 41456374)
17. Kudo, D., P. Rayman, C. Horton, M. K. Cathcart, R. M. Bukowski, M. Thornton, C. Tannenbaum, and J. H. Finke. 2003. Gangliosides expressed by the renal cell carcinoma cell line SK-RC-45 are involved in tumor-induced apoptosis of T cells. Cancer Res. 63: 1676-1683. (Pubitemid 36373661)
18. Biswas, S., K. Biswas, A. Richmond, J. Ko, S. Ghosh, M. Simmons, P. Rayman, B. Rini, I. Gill, C. S. Tannenbaum, and J. H. Finke. 2009. Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction. J. Immunol. 183: 5050-5058.
19. McKallip, R., R. Li, and S. Ladisch. 1999. Tumor gangliosides inhibit the tumorspecific immune response. J. Immunol. 163: 3718-3726. (Pubitemid 29450894)
20. Glasebrook, A. L., and F. W. Fitch. 1979. T-cell lines which cooperate in generation of specific cytolytic activity. Nature 278: 171-173. (Pubitemid 9146538)
21. Ladisch, S., and B. Gillard. 1985. A solvent partition method for microscale ganglioside purification. Anal. Biochem. 146: 220-231. (Pubitemid 15093069)
22. + CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity. J. Immunol. 181: 4716-4722.
23. Feldmann, J., I. Callebaut, G. Raposo, S. Certain, D. Bacq, C. Dumont, N. Lambert, M. Ouachée-Chardin, G. Chedeville, H. Tamary, et al. 2003. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115: 461-473. (Pubitemid 37456808)
24. Liu, Y., S. Yan, A. Wondimu, D. Bob, M. Weiss, K. Sliwinski, J. Villar, V. Notario, M. Sutherland, A. M. Colberg-Poley, and S. Ladisch. 2010. Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene 29: 3297-3306.
25. Li, R., D. Gage, and S. Ladisch. 1993. Biosynthesis and shedding of murine lymphoma gangliosides. Biochim. Biophys. Acta 1170: 283-290. (Pubitemid 23328738)
26. Pores-Fernando, A. T., R. A. Bauer, G. A. Wurth, and A. Zweifach. 2005. Exocytic responses of single leukaemic human cytotoxic T lymphocytes stimulated by agents that bypass the T cell receptor. J. Physiol. 567: 891-903. (Pubitemid 41387832)
27. Grayson, G., and S. Ladisch. 1992. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. Cell. Immunol. 139: 18-29.
28. Anikeeva, N., and Y. Sykulev. 2011. Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes. Immunol. Res. 51: 183-194.
29. Jenkins, M. R., A. Tsun, J. C. Stinchcombe, and G. M. Griffiths. 2009. The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse. Immunity 31: 621-631.
30. Quann, E. J., X. Liu, G. Altan-Bonnet, and M. Huse. 2011. A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat. Immunol. 12: 647-654.
31. Berg, N. N., L. G. Puente, W. Dawicki, and H. L. Ostergaard. 1998. Sustained TCR signaling is required for mitogen-activated protein kinase activation and degranulation by cytotoxic T lymphocytes. J. Immunol. 161: 2919-2924. (Pubitemid 28425714)
32. Puente, L. G., J. C. Stone, and H. L. Ostergaard. 2000. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins. J. Immunol. 165: 6865-6871. (Pubitemid 32001155)
33. Pores-Fernando, A. T., M. Y. Ranaghan, and A. Zweifach. 2009. No specific subcellular localization of protein kinase C is required for cytotoxic T cell granule exocytosis. J. Biol. Chem. 284: 25107-25115.
34. Spitaler, M., and D. A. Cantrell. 2004. Protein kinase C and beyond. Nat. Immunol. 5: 785-790. (Pubitemid 39172971)
35. + tumor-infiltrating T cells. Cancer Res. 67: 11447-11454.
36. Dráberová, L., L. Dudková, M. Boubelík, H. Tolarová, F. Smíd, and P. Dráber. 2003. Exogenous administration of gangliosides inhibits FcεRI-mediated mast cell degranulation by decreasing the activity of phospholipase Cγ. J. Immunol. 171: 3585-3593. (Pubitemid 37254561)
37. Küçük, O., J. Stoner-Picking, S. Yachnin, L. I. Gordon, R. M. Williams, L. J. Lis, and M. P. Westerman. 1994. Inhibition of cytolytic T lymphocyte activity by oxysterols. Lipids 29: 657-660. (Pubitemid 24282375)
38. Calcinotto, A., P. Filipazzi, M. Grioni, M. Iero, A. De Milito, A. Ricupito, A. Cova, R. Canese, E. Jachetti, M. Rossetti, et al. 2012. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 72: 2746-2756.
39. Hoskin, D. W., J. S. Mader, S. J. Furlong, D. M. Conrad, and J. Blay. 2008. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells. [Review] Int. J. Oncol. 32: 527-535. (Pubitemid 351330458)
40. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141. (Pubitemid 44066829)
41. Catalano, A., P. Caprari, S. Moretti, M. Faronato, L. Tamagnone, and A. Procopio. 2006. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 107: 3321-3329.
42. + tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J. Immunol. 167: 5042-5051.
43. Ménasché, G., J. Feldmann, A. Fischer, and G. de Saint Basile. 2005. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol. Rev. 203: 165-179. (Pubitemid 40179701)
44. Wong, C. G., S. Ladisch, and C. C. Sweeley. 1983. Hepatic ganglioside abnormalities in a patient with familial erythrophagocytic lymphohistiocytosis. Pediatr. Res. 17: 413-417. (Pubitemid 13135226)
45. Ladisch, S., D. G. Poplack, B. Holiman, and R. M. Blaese. 1978. Immunodeficiency in familial erythrophagocytic lymphohistiocytosis. Lancet 311: 581-583. (Pubitemid 8307417)
46. Egeler, R. M., R. Shapiro, B. Loechelt, and A. Filipovich. 1996. Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J. Pediatr. Hematol. Oncol. 18: 340-345. (Pubitemid 26359249)